📰 Fed Cir News
Page 2 - Fed Cir News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Fed Cir. Real-time updates on events, politics, business and more.
April 27, 2022
The effects of the ‘skinny label’ decision are still being felt across pharma. MaryAnne Armstrong of Birch, Stewart, Kolasch & Birch revisits GSK v Teva.
March 10, 2022
The US Court of Appeals for the Federal Circuit revived a Petitioner’s validity challenge seeking ex parte review at the US Patent & Trademark Office…
March 10, 2022
The US Court of Appeals for the Federal Circuit revived a petitioner’s validity challenge seeking ex parte review at the US Patent & Trademark Office (PTO), reversing a district court...
February 16, 2022
IAM is a unique and timely intelligence service that treats IP as a business asset and tool rather than simply as a legal right, informing boardrooms worldwide.
January 5, 2022
A duo of cases from the Federal Circuit has added complexities to the drafting of patent applications for antibody inventions, explain Hailey Bureau of BSKB and Olayinka Oladele of the Thurgood Marshall School of Law.
December 2, 2021
Finnegan attorneys Paul Browning, Christopher Johns, Sara Leiman and Yelena Morozova explain some of the differences between patent-eligibility standards in the U.S. and those in other parts of the world.
October 23, 2021
FRAND litigation is international in nature; it is rarely restricted to the United States.
April 9, 2021
Introduction It has been almost three years since the 25% duties on steel imports and the 10% duties on aluminium imports pursuant to Section 232 of the Trade Expansion Act 1962 were first imposed by Presidential Proclamation 9705 and legal challenges are proliferating and there is renewed legislative interest in Section 232 reform.(1) For those looking for any signs of a swift removal of the duties, the wait continues. The administrations rapid decision to reinstate the Section 232 duties on a...
March 15, 2021
On 1 March 2021 the Supreme Court heard oral arguments in United States v Arthrex (19–1434). This case addresses whether administrative patent judges (APJs) – who preside over inter partes reviews at the United States Patent and Trademark Office (USPTO) – are unconstitutionally appointed principal officers and, if so, whether that constitutional violation can be cured by severing for cause employment protections for APJs. If the Supreme Court in Arthrex concludes that APJs are unconsti...
February 12, 2021
Crocs challenger allowed to appeal patent suit 12-02-2021 24-10-2019 Mojave Desert Holdings has been allowed to substitute U.S.A Dawgs in the appeal case following its acquisition of all U.S.A Dawgs assets in 2018 after the sandal-maker’s bankruptcy. Crocs contested that Mojave Holdings should act as substitute for the case. It also claimed Mojave lacks standing in picking up U.S.A Dawg’s appeal case as it does not face a potential suit. The Crocs figurative patent is filed under US number ...